Natural Occurring Compounds Inhibit Osteoclastogenesis via Targeting NFATc1-related Signaling Pathways

Author:

Wang Jun1,Zheng Haishi2,Ma Rui3

Affiliation:

1. Department of Anesthesiology, The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, No.5 Weiyang West Road, Qindu District, Xianyang, Shaanxi, China

2. Department of Thoracic Surgery, Beijing Chaoyang Hospital, the Affiliated Hospital of Capital Medical University, No. 8, South Workers Stadium, Beijing, China

3. Department of Anesthesiology, Xi'an Children's Hospital, Xi'an, China

Abstract

Osteoclasts are originated from monocytic precursors of the hematopoietic lineage. Regulation of gene expression by transcription factors is one of the major mechanisms for controlling cellular functions. This is particularly important in the process of osteoclast production. As a main regulatory transcriptional factor, nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) plays a significant role in osteoclast differentiation. Although current studies focus on the regulatory effects of treatment in the process of osteoclastogenesis, many of these drugs possess cytotoxicity which is harmful to bone formation. Naturally occurring compounds with less or no side effects are most required in present clinical and fundamental study. In this paper, we summarize several plant-derived compounds in inhibiting osteoclastogenesis.

Funder

Chinese postdoctoral science foundation

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3